Roche Holding | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
AbbVie USD 700M 90M 2025-03
Alcon AG USD 49M 1000K 2025-03
Amgen USD 694M 29M 2025-06
AstraZeneca 303M 126M 2025-06
Bayer 495M 89M 2025-06
Biogen USD 72.6M 12.6M 2025-06
Bristol-Myers Squibb USD 485M 9M 2025-06
Eli Lilly USD 249M 5.3M 2025-06
Fresenius 86M 30M 2025-06
Fresenius Medical Care EUR 96.58M 15.58M 2025-06
Galapagos EUR 780K 49.34M 2025-03
Genmab DKK 9M 4M 2025-06
Gilead Sciences USD 254M 6M 2025-06
GlaxoSmithKline 184M 22M 2025-06
GRIFOLS EUR 202.71M 94.07M 2024-06
Hikma Pharmaceutical 22M 9M 2024-06
Lonza CHF 70M 11M 2024-12
Merck 79M 1000K 2025-06
Merck USD 305M 8M 2025-06
Novartis USD 289M 19M 2025-06
Orion 1.2M 200K 2025-06
Pfizer USD 654M 0 2025-06
Philips 80M 24M 2025-06
Recordati EUR 24.49M 6.41M 2025-06
Regeneron Pharmaceuticals USD 3.6M 5.1M 2025-06
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 148M 65M 2025-06
UCB 108M 16M 2024-12


Roche Holding Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.